Coherus BioSciences to Report Second Quarter 2016 Financial Results on August 9th
July 25 2016 - 11:00AM
Coherus BioSciences, Inc. (Nasdaq:CHRS), today announced that its
second quarter 2016 financial results will be released on August 9,
2016. At 4:30 p.m. Eastern Time, Coherus’ management will
host a conference call to discuss the results for the quarter and
provide a general business update.
Financial results will be released after market close on
Tuesday, August 9, 2016 and posted at
http://investors.coherus.com.
Conference Call Information When: Tuesday,
August 9, 2016 at 4:30 p.m. ET Dial-in: (844) 452-6826 (toll free)
or (765) 507-2587 (International) Conference ID: 46774291
Webcast: http://investors.coherus.com Please join the
conference call at least 10 minutes early to register. The
webcast will be archived on the Coherus website.
About Coherus BioSciences, Inc. Coherus is a
leading global biosimilar platform company that develops and
commercializes high-quality therapeutics for major regulated
markets. Biosimilars are intended for use in place of existing,
branded biologics to treat a range of chronic and often
life-threatening diseases, with the potential to reduce costs and
expand patient access. Composed of a team of proven industry
veterans with world-class expertise in process science, analytical
characterization, protein production and clinical-regulatory
development, Coherus is positioned as a leader in the global
biosimilar marketplace. Coherus is advancing three late-stage
clinical products towards commercialization, CHS-1701
(pegfilgrastim biosimilar), CHS-0214 (etanercept biosimilar) and
CHS-1420 (adalimumab biosimilar), as well as developing a robust
pipeline of future products in four therapeutic areas, oncology,
immunology (anti-TNF), ophthalmology and multiple sclerosis. For
additional information, please visit www.coherus.com.
CONTACT:
Patrick O’Brien
Senior Vice President, Investor Relations
Coherus BioSciences, Inc.
pobrien@coherus.com
+1 (650) 649-3527
Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From Aug 2024 to Sep 2024
Coherus BioSciences (NASDAQ:CHRS)
Historical Stock Chart
From Sep 2023 to Sep 2024